Showing results (1-10 of 610) with videos related to
Sort By:
Pageof 61
The New Zealand Medical Journal|July 13, 2011
Beta agonist use during asthma exacerbations: how much is too much?Mitesh Patel, Kyle Perrin, Richard BeasleyRespirology (Carlton, Vic.)|January 30, 2013
Accuracy of patient self-report as a measure of inhaled asthma medication useMitesh Patel, Kyle Perrin, Alison Pritchard, et al.The Journal of Allergy and Clinical Immunology. in Practice|November 16, 2013
Use of metered-dose inhaler electronic monitoring in a real-world asthma randomized controlled trialMitesh Patel, Janine Pilcher, Justin Travers, et al.Expert Review of Respiratory Medicine|October 22, 2013
Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma?Mitesh Patel, Janine Pilcher, Richard BeasleyCurrent Opinion in Allergy and Clinical Immunology|October 6, 2012
The β-2 agonist debate: is there still a problem?Mitesh Patel, Philippa Shirtcliffe, Richard BeasleyTranslational Respiratory Medicine|May 29, 2016
The effect of high concentration oxygen therapy on PaCO2 in acute and chronic respiratory disordersJanine Pilcher, Kyle Perrin, Richard BeasleyThe New Zealand Medical Journal|August 4, 2009
Honey in the treatment of burns: a systematic review and meta-analysis of its efficacyMeme Wijesinghe, Mark Weatherall, Kyle Perrin, et al.Journal of the Royal Society of Medicine|May 24, 2012
Proposed MHRA changes to UK children's paracetamol dosing recommendations: modelling studySally Eyers, James Fingleton, Kyle Perrin, et al.Expert Review of Respiratory Medicine|May 17, 2015
Oxygen therapy in acute exacerbations of chronic obstructive pulmonary diseaseJanine Pilcher, Mark Weatherall, Kyle Perrin, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 10, 2010
Long-acting beta-agonists and asthma death: how useful are different study designs to evaluate the potential association?Mark Weatherall, Meme Wijesinghe, Kyle Perrin, et al.Pageof 61